Adipokines are associated with pediatric multiple sclerosis risk and course
•Obesity during adolescence is a risk factor for multiple sclerosis.•We explored levels of inflammatory adipokines in pediatric MS compared to controls.•Pediatric MS patients had higher levels of leptin and FABP4 than controls.•Higher levels of adiponectin were associated with a lower hazard of rela...
Saved in:
Published in | Multiple sclerosis and related disorders Vol. 36; p. 101384 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier B.V
01.11.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | •Obesity during adolescence is a risk factor for multiple sclerosis.•We explored levels of inflammatory adipokines in pediatric MS compared to controls.•Pediatric MS patients had higher levels of leptin and FABP4 than controls.•Higher levels of adiponectin were associated with a lower hazard of relapse.•Adipokines could serve as biomarkers and therapeutic targets of for early MS.
Obesity during adolescence confers an increased risk of multiple sclerosis (MS) in both adults and children. However, obesity-mediated inflammatory mechanisms require elucidation. In models of MS, leptin and fatty acid binding protein-4 (FABP-4) have been identified as proinflammatory adipokines, while adiponectin has anti-inflammatory effects.
Morning serum samples from 32 pediatric MS (POMS) patients (22 females;10 males) and 67 pediatric healthy controls (PHC) (47 females; 20 males) followed at Massachusetts General Hospital were studied. Levels of leptin, FABP-4 and adiponectin were compared between POMS and PHC groups, adjusting for sex, age and vitamin D3 levels. Associations between each marker and the time to next relapse was assessed using a Cox proportional hazards model. The association between each marker and EDSS was assessed using linear regression.
Pediatric MS patients had significantly higher levels of leptin and FABP4 and significantly lower adiponectin than healthy controls. Higher levels of adiponectin were associated with a lower hazard of relapse. Similar differences were observed between POMS and PHC males for both leptin and adiponectin, and within females for FABP4. In females with MS, there was a trend for a positive association between higher leptin levels and higher disability scores. In males with MS, paradoxically, higher leptin levels were associated with longer time to next relapse. All these results remained significant after adjusting for Vitamin D.
FABP4 and leptin levels are higher, while adiponectin levels are lower in pediatric MS compared to controls in sex-specific patterns. These adipokines could serve as biomarkers and therapeutic targets of disease risk and course in early forms of MS. |
---|---|
AbstractList | BACKGROUNDObesity during adolescence confers an increased risk of multiple sclerosis (MS) in both adults and children. However, obesity-mediated inflammatory mechanisms require elucidation. In models of MS, leptin and fatty acid binding protein-4 (FABP-4) have been identified as proinflammatory adipokines, while adiponectin has anti-inflammatory effects. METHODSMorning serum samples from 32 pediatric MS (POMS) patients (22 females;10 males) and 67 pediatric healthy controls (PHC) (47 females; 20 males) followed at Massachusetts General Hospital were studied. Levels of leptin, FABP-4 and adiponectin were compared between POMS and PHC groups, adjusting for sex, age and vitamin D3 levels. Associations between each marker and the time to next relapse was assessed using a Cox proportional hazards model. The association between each marker and EDSS was assessed using linear regression. RESULTSPediatric MS patients had significantly higher levels of leptin and FABP4 and significantly lower adiponectin than healthy controls. Higher levels of adiponectin were associated with a lower hazard of relapse. Similar differences were observed between POMS and PHC males for both leptin and adiponectin, and within females for FABP4. In females with MS, there was a trend for a positive association between higher leptin levels and higher disability scores. In males with MS, paradoxically, higher leptin levels were associated with longer time to next relapse. All these results remained significant after adjusting for Vitamin D. CONCLUSIONSFABP4 and leptin levels are higher, while adiponectin levels are lower in pediatric MS compared to controls in sex-specific patterns. These adipokines could serve as biomarkers and therapeutic targets of disease risk and course in early forms of MS. •Obesity during adolescence is a risk factor for multiple sclerosis.•We explored levels of inflammatory adipokines in pediatric MS compared to controls.•Pediatric MS patients had higher levels of leptin and FABP4 than controls.•Higher levels of adiponectin were associated with a lower hazard of relapse.•Adipokines could serve as biomarkers and therapeutic targets of for early MS. Obesity during adolescence confers an increased risk of multiple sclerosis (MS) in both adults and children. However, obesity-mediated inflammatory mechanisms require elucidation. In models of MS, leptin and fatty acid binding protein-4 (FABP-4) have been identified as proinflammatory adipokines, while adiponectin has anti-inflammatory effects. Morning serum samples from 32 pediatric MS (POMS) patients (22 females;10 males) and 67 pediatric healthy controls (PHC) (47 females; 20 males) followed at Massachusetts General Hospital were studied. Levels of leptin, FABP-4 and adiponectin were compared between POMS and PHC groups, adjusting for sex, age and vitamin D3 levels. Associations between each marker and the time to next relapse was assessed using a Cox proportional hazards model. The association between each marker and EDSS was assessed using linear regression. Pediatric MS patients had significantly higher levels of leptin and FABP4 and significantly lower adiponectin than healthy controls. Higher levels of adiponectin were associated with a lower hazard of relapse. Similar differences were observed between POMS and PHC males for both leptin and adiponectin, and within females for FABP4. In females with MS, there was a trend for a positive association between higher leptin levels and higher disability scores. In males with MS, paradoxically, higher leptin levels were associated with longer time to next relapse. All these results remained significant after adjusting for Vitamin D. FABP4 and leptin levels are higher, while adiponectin levels are lower in pediatric MS compared to controls in sex-specific patterns. These adipokines could serve as biomarkers and therapeutic targets of disease risk and course in early forms of MS. Obesity during adolescence confers an increased risk of multiple sclerosis (MS) in both adults and children. However, obesity-mediated inflammatory mechanisms require elucidation. In models of MS, leptin and fatty acid binding protein-4 (FABP-4) have been identified as proinflammatory adipokines, while adiponectin has anti-inflammatory effects. Morning serum samples from 32 pediatric MS (POMS) patients (22 females;10 males) and 67 pediatric healthy controls (PHC) (47 females; 20 males) followed at Massachusetts General Hospital were studied. Levels of leptin, FABP-4 and adiponectin were compared between POMS and PHC groups, adjusting for sex, age and vitamin D3 levels. Associations between each marker and the time to next relapse was assessed using a Cox proportional hazards model. The association between each marker and EDSS was assessed using linear regression. Pediatric MS patients had significantly higher levels of leptin and FABP4 and significantly lower adiponectin than healthy controls. Higher levels of adiponectin were associated with a lower hazard of relapse. Similar differences were observed between POMS and PHC males for both leptin and adiponectin, and within females for FABP4. In females with MS, there was a trend for a positive association between higher leptin levels and higher disability scores. In males with MS, paradoxically, higher leptin levels were associated with longer time to next relapse. All these results remained significant after adjusting for Vitamin D. FABP4 and leptin levels are higher, while adiponectin levels are lower in pediatric MS compared to controls in sex-specific patterns. These adipokines could serve as biomarkers and therapeutic targets of disease risk and course in early forms of MS. |
ArticleNumber | 101384 |
Author | Healy, Brian C Misra, Madhusmita Chitnis, Tanuja Gombolay, Grace Saxena, Shrishti Keyhanian, Kiandokht |
Author_xml | – sequence: 1 givenname: Kiandokht surname: Keyhanian fullname: Keyhanian, Kiandokht organization: Ann Romney Center for Neurological Diseases, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA – sequence: 2 givenname: Shrishti surname: Saxena fullname: Saxena, Shrishti organization: Ann Romney Center for Neurological Diseases, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA – sequence: 3 givenname: Grace surname: Gombolay fullname: Gombolay, Grace organization: Ann Romney Center for Neurological Diseases, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA – sequence: 4 givenname: Brian C surname: Healy fullname: Healy, Brian C organization: Ann Romney Center for Neurological Diseases, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA – sequence: 5 givenname: Madhusmita surname: Misra fullname: Misra, Madhusmita organization: Department of Pediatric Endocrinology, Massachusetts General Hospital, Boston, MA, USA – sequence: 6 givenname: Tanuja orcidid: 0000-0002-9897-4422 surname: Chitnis fullname: Chitnis, Tanuja email: tchitnis@partners.org, tchitnis@rics.bwh.harvard.edu organization: Ann Romney Center for Neurological Diseases, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31550559$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kMlOwzAQhi1URMvyBEjIRy4pthM7yYFDVbEJJC5wtlx7Ilyy4UlAvD0uLT3iy3hG_z_Ld0wmbdcCIeeczTnj6mo9b9AENxeMl5tKWmQHZCYE5wlLpZrs_1kxJWeIaxafkjxT_IhMUy4lk7KckceF83337ltAagJQg9hZbwZw9MsPb7QHF7PgLW3GevB9DRRtDaFDjzR4fKemddR2Y0A4JYeVqRHOdvGEvN7evCzvk6fnu4fl4imxqSyHRLi0UAUTlhtbMKdcXilhSrVihXTArIVcOlcpqPKVy2xeMjAqy7ICINoym56Qy23fPnQfI-CgG48W6tq00I2ohShzLnLG0ihNt1IbN8YAle6Db0z41pzpDUi91r8g9Qak3oKMrovdgHHVgNt7_rBFwfVWAPHMTw9Bo_XQ2ggrgB206_y_A34AppiHQg |
CitedBy_id | crossref_primary_10_3389_fimmu_2022_1038393 crossref_primary_10_1186_s12883_022_02913_w crossref_primary_10_3390_jcm10122689 crossref_primary_10_3389_fneur_2023_1207617 crossref_primary_10_1016_j_celrep_2021_109112 crossref_primary_10_1016_S2352_4642_21_00157_7 crossref_primary_10_1016_j_msard_2021_103311 crossref_primary_10_3390_biomedicines11061692 crossref_primary_10_1016_j_spen_2023_101049 crossref_primary_10_3389_fneur_2023_1304610 crossref_primary_10_1016_j_msard_2021_102910 crossref_primary_10_1016_j_msard_2023_104768 crossref_primary_10_1177_1352458521995484 crossref_primary_10_1212_NXI_0000000000001044 crossref_primary_10_3390_jcm13020464 crossref_primary_10_1016_j_molmet_2023_101783 crossref_primary_10_2478_cipms_2023_0017 crossref_primary_10_3389_fneur_2022_802380 crossref_primary_10_1177_13524585231171047 |
Cites_doi | 10.1002/acn3.365 10.1212/WNL.0b013e3181c0d6e0 10.1073/pnas.0408995102 10.1161/CIRCULATIONAHA.106.647503 10.1212/WNL.0000000000000560 10.1210/jc.2004-0395 10.5114/ninp.2012.27211 10.1177/1352458513484547 10.1177/1352458514527864 10.1074/jbc.M109.097907 10.1002/eji.201242836 10.1001/archneurol.2008.505 10.1038/nature05485 10.2337/db13-0436 10.1002/1521-4141(200105)31:5<1324::AID-IMMU1324>3.0.CO;2-Y 10.4049/jimmunol.1000588 10.1212/WNL.0b013e31828154f3 10.1038/nri2921 10.1186/1471-2377-13-172 10.1016/S0165-5728(03)00154-1 10.1038/ncomms8687 10.1155/2008/627463 10.4049/jimmunol.1200935 10.1159/000317393 10.1212/WNL.33.11.1444 10.1111/j.1468-1331.2009.02701.x 10.1016/j.clim.2013.03.014 |
ContentType | Journal Article |
Copyright | 2019 Elsevier B.V. Copyright © 2019 Elsevier B.V. All rights reserved. |
Copyright_xml | – notice: 2019 Elsevier B.V. – notice: Copyright © 2019 Elsevier B.V. All rights reserved. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1016/j.msard.2019.101384 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2211-0356 |
EndPage | 101384 |
ExternalDocumentID | 10_1016_j_msard_2019_101384 31550559 S221103481930361X |
Genre | Journal Article |
GroupedDBID | --- --K --M .1- .FO .~1 0R~ 1P~ 1~. 1~5 4.4 457 4G. 53G 5VS 7-5 8P~ AACTN AADPK AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAXLA AAXUO ABBQC ABCQJ ABGSF ABJNI ABLVK ABMAC ABMZM ABTEW ABUDA ABXDB ABYKQ ACDAQ ACGFS ACRLP ADBBV ADEZE ADMUD ADUVX AEBSH AEHWI AEKER AENEX AEVXI AFKWA AFRHN AFTJW AFXIZ AGHFR AGUBO AGWIK AGYEJ AIEXJ AIKHN AITUG AJBFU AJOXV AJRQY AJUYK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX AXJTR BKOJK BLXMC BNPGV DOVZS EBS EFJIC EFLBG EJD FDB FEDTE FIRID FNPLU FYGXN GBLVA HVGLF HZ~ KOM LCYCR M41 MO0 MOBAO O-L O9- OAUVE OP~ P-8 P-9 PC. Q38 RIG ROL SDF SEL SPCBC SSH SSN SSU SSZ T5K Z5R ~G- AKRWK CGR CUY CVF ECM EIF NPM AAXKI AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c359t-2d386802c1ac80d6d7f62a96b085de0cce75ddf6ef7bd4c790ea64448ee6804c3 |
IEDL.DBID | .~1 |
ISSN | 2211-0348 |
IngestDate | Fri Aug 16 07:49:51 EDT 2024 Thu Sep 12 17:37:27 EDT 2024 Thu May 23 23:43:06 EDT 2024 Fri Feb 23 02:48:55 EST 2024 |
IsPeerReviewed | false |
IsScholarly | true |
Keywords | Obesity Multiple sclerosis FABP4 Adipokines Pediatric |
Language | English |
License | Copyright © 2019 Elsevier B.V. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c359t-2d386802c1ac80d6d7f62a96b085de0cce75ddf6ef7bd4c790ea64448ee6804c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-9897-4422 |
PMID | 31550559 |
PQID | 2297127003 |
PQPubID | 23479 |
PageCount | 1 |
ParticipantIDs | proquest_miscellaneous_2297127003 crossref_primary_10_1016_j_msard_2019_101384 pubmed_primary_31550559 elsevier_sciencedirect_doi_10_1016_j_msard_2019_101384 |
PublicationCentury | 2000 |
PublicationDate | November 2019 2019-Nov 2019-11-00 20191101 |
PublicationDateYYYYMMDD | 2019-11-01 |
PublicationDate_xml | – month: 11 year: 2019 text: November 2019 |
PublicationDecade | 2010 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | Multiple sclerosis and related disorders |
PublicationTitleAlternate | Mult Scler Relat Disord |
PublicationYear | 2019 |
Publisher | Elsevier B.V |
Publisher_xml | – name: Elsevier B.V |
References | Hietaharju, Kuusisto, Nieminen, Vuolteenaho, Elovaara, Moilanen (bib0021) 2010; 17 Xu, Tso, Cheung (bib0027) 2007; 115 Matarese, Carrieri, La Cava (bib0009) 2005; 102 Piccio, Cantoni, Henderson (bib0018) 2013; 43 Drew, Xu, Racke (bib0017) 2008 Luukkaa, Pesonen, Huhtaniemi (bib0038) 1998; 83 Messina, Vargas-Lowy, Musallam (bib0011) 2013; 13 Musabak, Demirkaya, Genç, Ilikci, Odabasi (bib0020) 2011; 18 Musabak, Demirkaya, Genc, Ilikci, Odabasi (bib0030) 2011; 18 Kraszula, Jasinska, Eusebio, Kuna, Glabinski, Pietruczuk (bib0031) 2012; 46 Matarese, Sanna, Giacomo (bib0010) 2001; 31 Munger, Chitnis, Ascherio (bib0001) 2009; 73 Shibata, Tada, Hau (bib0019) 2015; 6 Bove, Healy, Musallam (bib0014) 2018 Gorman, Healy, Polgar-Turcsanyi, Chitnis (bib0023) 2009; 66 Lublin, Reingold, Cohen (bib0026) 2014; 83 Batocchi, Rotondi, Caggiula (bib0012) 2003; 139 Ouchi, Parker, Lugus, Walsh (bib0007) 2011; 11 Correale, Ysrraelit, Gaitan (bib0032) 2010; 185 Chitnis (bib0022) 2013; 149 Hui, Li, Zhou (bib0028) 2010; 285 Garin-Shkolnik, Rudich, Hotamisligil, Rubinstein (bib0016) 2014; 63 Langer-Gould, Brara, Beaber, Koebnick (bib0002) 2013; 80 Sheng, Sheng, Zhao (bib0015) 2015; 19 Kraszula, Jasińska, Eusebio, Kuna, Głąbiński, Pietruczuk (bib0013) 2012; 46 Bove, Musallam, Healy (bib0039) 2014; 20 Chitnis, Graves, Weinstock-Guttman (bib0003) 2016; 3 Krupp, Tardieu, Amato (bib0024) 2013; 19 Piccio, Cantoni, Henderson (bib0029) 2013; 43 Kershaw, Flier (bib0005) 2004; 89 Ouchi, Ohashi, Shibata, Murohara (bib0004) 2012; 74 Hotamisligil (bib0006) 2006; 444 Kurtzke (bib0025) 1983; 33 Procaccini, De Rosa, Galgani (bib0008) 2012; 189 Chitnis (10.1016/j.msard.2019.101384_bib0003) 2016; 3 Ouchi (10.1016/j.msard.2019.101384_bib0004) 2012; 74 Piccio (10.1016/j.msard.2019.101384_bib0029) 2013; 43 Gorman (10.1016/j.msard.2019.101384_bib0023) 2009; 66 Musabak (10.1016/j.msard.2019.101384_bib0030) 2011; 18 Bove (10.1016/j.msard.2019.101384_bib0014) 2018 Shibata (10.1016/j.msard.2019.101384_bib0019) 2015; 6 Messina (10.1016/j.msard.2019.101384_bib0011) 2013; 13 Hui (10.1016/j.msard.2019.101384_bib0028) 2010; 285 Kurtzke (10.1016/j.msard.2019.101384_bib0025) 1983; 33 Matarese (10.1016/j.msard.2019.101384_bib0010) 2001; 31 Chitnis (10.1016/j.msard.2019.101384_bib0022) 2013; 149 Correale (10.1016/j.msard.2019.101384_bib0032) 2010; 185 Garin-Shkolnik (10.1016/j.msard.2019.101384_bib0016) 2014; 63 Langer-Gould (10.1016/j.msard.2019.101384_bib0002) 2013; 80 Kershaw (10.1016/j.msard.2019.101384_bib0005) 2004; 89 Sheng (10.1016/j.msard.2019.101384_bib0015) 2015; 19 Bove (10.1016/j.msard.2019.101384_bib0039) 2014; 20 Hotamisligil (10.1016/j.msard.2019.101384_bib0006) 2006; 444 Drew (10.1016/j.msard.2019.101384_bib0017) 2008 Xu (10.1016/j.msard.2019.101384_bib0027) 2007; 115 Lublin (10.1016/j.msard.2019.101384_bib0026) 2014; 83 Procaccini (10.1016/j.msard.2019.101384_bib0008) 2012; 189 Batocchi (10.1016/j.msard.2019.101384_bib0012) 2003; 139 Munger (10.1016/j.msard.2019.101384_bib0001) 2009; 73 Ouchi (10.1016/j.msard.2019.101384_bib0007) 2011; 11 Kraszula (10.1016/j.msard.2019.101384_bib0013) 2012; 46 Kraszula (10.1016/j.msard.2019.101384_bib0031) 2012; 46 Musabak (10.1016/j.msard.2019.101384_bib0020) 2011; 18 Luukkaa (10.1016/j.msard.2019.101384_bib0038) 1998; 83 Piccio (10.1016/j.msard.2019.101384_bib0018) 2013; 43 Krupp (10.1016/j.msard.2019.101384_bib0024) 2013; 19 Hietaharju (10.1016/j.msard.2019.101384_bib0021) 2010; 17 Matarese (10.1016/j.msard.2019.101384_bib0009) 2005; 102 |
References_xml | – volume: 444 start-page: 860 year: 2006 ident: bib0006 article-title: Inflammation and metabolic disorders publication-title: Nature contributor: fullname: Hotamisligil – volume: 189 start-page: 2941 year: 2012 end-page: 2953 ident: bib0008 article-title: Leptin-induced mTOR activation defines a specific molecular and transcriptional signature controlling CD4+ effector T cell responses publication-title: J. Immunol. contributor: fullname: Galgani – volume: 3 start-page: 897 year: 2016 end-page: 907 ident: bib0003 article-title: Distinct effects of obesity and puberty on risk and age at onset of pediatric MS publication-title: Ann. Clin. Transl. Neurol. contributor: fullname: Weinstock-Guttman – volume: 63 start-page: 900 year: 2014 end-page: 911 ident: bib0016 article-title: FABP4 attenuates PPARγ and adipogenesis and is inversely correlated with PPARγ in adipose tissues publication-title: Diabetes contributor: fullname: Rubinstein – volume: 17 start-page: 332 year: 2010 end-page: 334 ident: bib0021 article-title: Elevated cerebrospinal fluid adiponectin and adipsin levels in patients with multiple sclerosis: a finnish co‐twin study publication-title: Eur. J. Neurol. contributor: fullname: Moilanen – volume: 43 start-page: 2089 year: 2013 end-page: 2100 ident: bib0029 article-title: Lack of adiponectin leads to increased lymphocyte activation and increased disease severity in a mouse model of multiple sclerosis publication-title: Eur. J. Immunol. contributor: fullname: Henderson – volume: 80 start-page: 548 year: 2013 end-page: 552 ident: bib0002 article-title: Childhood obesity and risk of pediatric multiple sclerosis and clinically isolated syndrome publication-title: Neurology contributor: fullname: Koebnick – volume: 185 start-page: 4948 year: 2010 end-page: 4958 ident: bib0032 article-title: Gender differences in 1,25 dihydroxyvitamin D3 immunomodulatory effects in multiple sclerosis patients and healthy subjects publication-title: J. Immunol. contributor: fullname: Gaitan – volume: 33 year: 1983 ident: bib0025 article-title: Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) publication-title: Neurology contributor: fullname: Kurtzke – volume: 66 start-page: 54 year: 2009 end-page: 59 ident: bib0023 article-title: Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis publication-title: Arch. Neurol. contributor: fullname: Chitnis – volume: 13 start-page: 172 year: 2013 ident: bib0011 article-title: Increased leptin and A-FABP levels in relapsing and progressive forms of MS publication-title: BMC Neurol. contributor: fullname: Musallam – volume: 19 start-page: 3635 year: 2015 end-page: 3642 ident: bib0015 article-title: Identifying the biomarkers of multiple sclerosis based on non-coding RNA signature publication-title: Eur. Rev. Med. Pharmacol. Sci. contributor: fullname: Zhao – volume: 139 start-page: 150 year: 2003 end-page: 154 ident: bib0012 article-title: Leptin as a marker of multiple sclerosis activity in patients treated with interferon-beta publication-title: J. Neuroimmunol. contributor: fullname: Caggiula – year: 2018 ident: bib0014 article-title: Fatty acid binding protein-4 is associated with disability in multiple sclerosis patients publication-title: Mult. Scler. contributor: fullname: Musallam – volume: 43 start-page: 2089 year: 2013 end-page: 2100 ident: bib0018 article-title: Lack of adiponectin leads to increased lymphocyte activation and increased disease severity in a mouse model of multiple sclerosis publication-title: Eur. J. Immunol. contributor: fullname: Henderson – volume: 19 start-page: 1261 year: 2013 end-page: 1267 ident: bib0024 article-title: International pediatric multiple sclerosis study group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions publication-title: Mult. Scler. J. contributor: fullname: Amato – volume: 285 start-page: 10273 year: 2010 end-page: 10280 ident: bib0028 article-title: Adipocyte fatty acid-binding protein modulates inflammatory responses in macrophages through a positive feedback loop involving c-Jun NH2-terminal kinases and activator protein-1 publication-title: J. Biol. Chem. contributor: fullname: Zhou – volume: 83 start-page: 278 year: 2014 end-page: 286 ident: bib0026 article-title: Defining the clinical course of multiple sclerosis: the 2013 revisions publication-title: Neurology contributor: fullname: Cohen – volume: 11 start-page: 85 year: 2011 ident: bib0007 article-title: Adipokines in inflammation and metabolic disease publication-title: Nat. Rev. Immunol. contributor: fullname: Walsh – volume: 83 start-page: 3243 year: 1998 end-page: 3246 ident: bib0038 article-title: Inverse correlation between serum testosterone and leptin in men publication-title: J. Clin. Endocrinol. Metab. contributor: fullname: Huhtaniemi – volume: 46 start-page: 22 year: 2012 end-page: 28 ident: bib0031 article-title: Evaluation of the relationship between leptin, resistin, adiponectin and natural regulatory T cells in relapsing-remitting multiple sclerosis publication-title: Neurol. Neurochir. Pol. contributor: fullname: Pietruczuk – volume: 102 start-page: 5150 year: 2005 end-page: 5155 ident: bib0009 article-title: Leptin increase in multiple sclerosis associates with reduced number of CD4(+)CD25+ regulatory T cells publication-title: Proc. Natl. Acad. Sci. USA contributor: fullname: La Cava – volume: 6 start-page: 7687 year: 2015 ident: bib0019 article-title: Adiponectin regulates psoriasiform skin inflammation by suppressing IL-17 production from γδ-T cells publication-title: Nat. Commun. contributor: fullname: Hau – volume: 20 start-page: 1584 year: 2014 end-page: 1592 ident: bib0039 article-title: Low testosterone is associated with disability in men with multiple sclerosis publication-title: Mult. Scler. contributor: fullname: Healy – volume: 89 start-page: 2548 year: 2004 end-page: 2556 ident: bib0005 article-title: Adipose tissue as an endocrine organ publication-title: J. Clin. Endocrinol. Metab. contributor: fullname: Flier – volume: 18 start-page: 57 year: 2011 end-page: 66 ident: bib0030 article-title: Serum adiponectin, TNF-alpha, IL-12p70, and IL-13 levels in multiple sclerosis and the effects of different therapy regimens publication-title: Neuroimmunomodulation contributor: fullname: Odabasi – volume: 74 start-page: 19 year: 2012 end-page: 30 ident: bib0004 article-title: Adipocytokines and obesity-linked disorders publication-title: Nagoya J. Med. Sci. contributor: fullname: Murohara – volume: 149 start-page: 192 year: 2013 end-page: 200 ident: bib0022 article-title: Role of puberty in multiple sclerosis risk and course publication-title: Clin. Immunol. contributor: fullname: Chitnis – volume: 31 start-page: 1324 year: 2001 end-page: 1332 ident: bib0010 article-title: Leptin potentiates experimental autoimmune encephalomyelitis in SJL female mice and confers susceptibility to males publication-title: Eur. J. Immunol. contributor: fullname: Giacomo – volume: 18 start-page: 57 year: 2011 end-page: 66 ident: bib0020 article-title: Serum adiponectin, TNF-α, IL-12p70, and IL-13 levels in multiple sclerosis and the effects of different therapy regimens publication-title: Neuroimmunomodulation contributor: fullname: Odabasi – year: 2008 ident: bib0017 article-title: PPAR-gamma: therapeutic potential for multiple sclerosis publication-title: PPAR Res. contributor: fullname: Racke – volume: 46 start-page: 22 year: 2012 end-page: 28 ident: bib0013 article-title: Evaluation of the relationship between leptin, resistin, adiponectin and natural regulatory T cells in relapsing-remitting multiple sclerosis publication-title: Neurol. Neurochir. Pol. contributor: fullname: Pietruczuk – volume: 115 start-page: 1537 year: 2007 end-page: 1543 ident: bib0027 article-title: Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study publication-title: Circulation contributor: fullname: Cheung – volume: 73 start-page: 1543 year: 2009 end-page: 1550 ident: bib0001 article-title: Body size and risk of MS in two cohorts of US women publication-title: Neurology contributor: fullname: Ascherio – year: 2018 ident: 10.1016/j.msard.2019.101384_bib0014 article-title: Fatty acid binding protein-4 is associated with disability in multiple sclerosis patients publication-title: Mult. Scler. contributor: fullname: Bove – volume: 3 start-page: 897 year: 2016 ident: 10.1016/j.msard.2019.101384_bib0003 article-title: Distinct effects of obesity and puberty on risk and age at onset of pediatric MS publication-title: Ann. Clin. Transl. Neurol. doi: 10.1002/acn3.365 contributor: fullname: Chitnis – volume: 73 start-page: 1543 year: 2009 ident: 10.1016/j.msard.2019.101384_bib0001 article-title: Body size and risk of MS in two cohorts of US women publication-title: Neurology doi: 10.1212/WNL.0b013e3181c0d6e0 contributor: fullname: Munger – volume: 74 start-page: 19 year: 2012 ident: 10.1016/j.msard.2019.101384_bib0004 article-title: Adipocytokines and obesity-linked disorders publication-title: Nagoya J. Med. Sci. contributor: fullname: Ouchi – volume: 102 start-page: 5150 year: 2005 ident: 10.1016/j.msard.2019.101384_bib0009 article-title: Leptin increase in multiple sclerosis associates with reduced number of CD4(+)CD25+ regulatory T cells publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.0408995102 contributor: fullname: Matarese – volume: 115 start-page: 1537 year: 2007 ident: 10.1016/j.msard.2019.101384_bib0027 article-title: Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.106.647503 contributor: fullname: Xu – volume: 83 start-page: 278 year: 2014 ident: 10.1016/j.msard.2019.101384_bib0026 article-title: Defining the clinical course of multiple sclerosis: the 2013 revisions publication-title: Neurology doi: 10.1212/WNL.0000000000000560 contributor: fullname: Lublin – volume: 89 start-page: 2548 year: 2004 ident: 10.1016/j.msard.2019.101384_bib0005 article-title: Adipose tissue as an endocrine organ publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jc.2004-0395 contributor: fullname: Kershaw – volume: 46 start-page: 22 year: 2012 ident: 10.1016/j.msard.2019.101384_bib0031 article-title: Evaluation of the relationship between leptin, resistin, adiponectin and natural regulatory T cells in relapsing-remitting multiple sclerosis publication-title: Neurol. Neurochir. Pol. doi: 10.5114/ninp.2012.27211 contributor: fullname: Kraszula – volume: 19 start-page: 1261 year: 2013 ident: 10.1016/j.msard.2019.101384_bib0024 article-title: International pediatric multiple sclerosis study group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions publication-title: Mult. Scler. J. doi: 10.1177/1352458513484547 contributor: fullname: Krupp – volume: 20 start-page: 1584 year: 2014 ident: 10.1016/j.msard.2019.101384_bib0039 article-title: Low testosterone is associated with disability in men with multiple sclerosis publication-title: Mult. Scler. doi: 10.1177/1352458514527864 contributor: fullname: Bove – volume: 285 start-page: 10273 year: 2010 ident: 10.1016/j.msard.2019.101384_bib0028 article-title: Adipocyte fatty acid-binding protein modulates inflammatory responses in macrophages through a positive feedback loop involving c-Jun NH2-terminal kinases and activator protein-1 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M109.097907 contributor: fullname: Hui – volume: 83 start-page: 3243 year: 1998 ident: 10.1016/j.msard.2019.101384_bib0038 article-title: Inverse correlation between serum testosterone and leptin in men publication-title: J. Clin. Endocrinol. Metab. contributor: fullname: Luukkaa – volume: 43 start-page: 2089 year: 2013 ident: 10.1016/j.msard.2019.101384_bib0018 article-title: Lack of adiponectin leads to increased lymphocyte activation and increased disease severity in a mouse model of multiple sclerosis publication-title: Eur. J. Immunol. doi: 10.1002/eji.201242836 contributor: fullname: Piccio – volume: 66 start-page: 54 year: 2009 ident: 10.1016/j.msard.2019.101384_bib0023 article-title: Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis publication-title: Arch. Neurol. doi: 10.1001/archneurol.2008.505 contributor: fullname: Gorman – volume: 444 start-page: 860 year: 2006 ident: 10.1016/j.msard.2019.101384_bib0006 article-title: Inflammation and metabolic disorders publication-title: Nature doi: 10.1038/nature05485 contributor: fullname: Hotamisligil – volume: 63 start-page: 900 year: 2014 ident: 10.1016/j.msard.2019.101384_bib0016 article-title: FABP4 attenuates PPARγ and adipogenesis and is inversely correlated with PPARγ in adipose tissues publication-title: Diabetes doi: 10.2337/db13-0436 contributor: fullname: Garin-Shkolnik – volume: 31 start-page: 1324 year: 2001 ident: 10.1016/j.msard.2019.101384_bib0010 article-title: Leptin potentiates experimental autoimmune encephalomyelitis in SJL female mice and confers susceptibility to males publication-title: Eur. J. Immunol. doi: 10.1002/1521-4141(200105)31:5<1324::AID-IMMU1324>3.0.CO;2-Y contributor: fullname: Matarese – volume: 185 start-page: 4948 year: 2010 ident: 10.1016/j.msard.2019.101384_bib0032 article-title: Gender differences in 1,25 dihydroxyvitamin D3 immunomodulatory effects in multiple sclerosis patients and healthy subjects publication-title: J. Immunol. doi: 10.4049/jimmunol.1000588 contributor: fullname: Correale – volume: 80 start-page: 548 year: 2013 ident: 10.1016/j.msard.2019.101384_bib0002 article-title: Childhood obesity and risk of pediatric multiple sclerosis and clinically isolated syndrome publication-title: Neurology doi: 10.1212/WNL.0b013e31828154f3 contributor: fullname: Langer-Gould – volume: 11 start-page: 85 year: 2011 ident: 10.1016/j.msard.2019.101384_bib0007 article-title: Adipokines in inflammation and metabolic disease publication-title: Nat. Rev. Immunol. doi: 10.1038/nri2921 contributor: fullname: Ouchi – volume: 13 start-page: 172 year: 2013 ident: 10.1016/j.msard.2019.101384_bib0011 article-title: Increased leptin and A-FABP levels in relapsing and progressive forms of MS publication-title: BMC Neurol. doi: 10.1186/1471-2377-13-172 contributor: fullname: Messina – volume: 139 start-page: 150 year: 2003 ident: 10.1016/j.msard.2019.101384_bib0012 article-title: Leptin as a marker of multiple sclerosis activity in patients treated with interferon-beta publication-title: J. Neuroimmunol. doi: 10.1016/S0165-5728(03)00154-1 contributor: fullname: Batocchi – volume: 19 start-page: 3635 year: 2015 ident: 10.1016/j.msard.2019.101384_bib0015 article-title: Identifying the biomarkers of multiple sclerosis based on non-coding RNA signature publication-title: Eur. Rev. Med. Pharmacol. Sci. contributor: fullname: Sheng – volume: 6 start-page: 7687 year: 2015 ident: 10.1016/j.msard.2019.101384_bib0019 article-title: Adiponectin regulates psoriasiform skin inflammation by suppressing IL-17 production from γδ-T cells publication-title: Nat. Commun. doi: 10.1038/ncomms8687 contributor: fullname: Shibata – year: 2008 ident: 10.1016/j.msard.2019.101384_bib0017 article-title: PPAR-gamma: therapeutic potential for multiple sclerosis publication-title: PPAR Res. doi: 10.1155/2008/627463 contributor: fullname: Drew – volume: 43 start-page: 2089 year: 2013 ident: 10.1016/j.msard.2019.101384_bib0029 article-title: Lack of adiponectin leads to increased lymphocyte activation and increased disease severity in a mouse model of multiple sclerosis publication-title: Eur. J. Immunol. doi: 10.1002/eji.201242836 contributor: fullname: Piccio – volume: 189 start-page: 2941 year: 2012 ident: 10.1016/j.msard.2019.101384_bib0008 article-title: Leptin-induced mTOR activation defines a specific molecular and transcriptional signature controlling CD4+ effector T cell responses publication-title: J. Immunol. doi: 10.4049/jimmunol.1200935 contributor: fullname: Procaccini – volume: 18 start-page: 57 year: 2011 ident: 10.1016/j.msard.2019.101384_bib0020 article-title: Serum adiponectin, TNF-α, IL-12p70, and IL-13 levels in multiple sclerosis and the effects of different therapy regimens publication-title: Neuroimmunomodulation doi: 10.1159/000317393 contributor: fullname: Musabak – volume: 46 start-page: 22 year: 2012 ident: 10.1016/j.msard.2019.101384_bib0013 article-title: Evaluation of the relationship between leptin, resistin, adiponectin and natural regulatory T cells in relapsing-remitting multiple sclerosis publication-title: Neurol. Neurochir. Pol. doi: 10.5114/ninp.2012.27211 contributor: fullname: Kraszula – volume: 33 year: 1983 ident: 10.1016/j.msard.2019.101384_bib0025 article-title: Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) publication-title: Neurology doi: 10.1212/WNL.33.11.1444 contributor: fullname: Kurtzke – volume: 17 start-page: 332 year: 2010 ident: 10.1016/j.msard.2019.101384_bib0021 article-title: Elevated cerebrospinal fluid adiponectin and adipsin levels in patients with multiple sclerosis: a finnish co‐twin study publication-title: Eur. J. Neurol. doi: 10.1111/j.1468-1331.2009.02701.x contributor: fullname: Hietaharju – volume: 18 start-page: 57 year: 2011 ident: 10.1016/j.msard.2019.101384_bib0030 article-title: Serum adiponectin, TNF-alpha, IL-12p70, and IL-13 levels in multiple sclerosis and the effects of different therapy regimens publication-title: Neuroimmunomodulation doi: 10.1159/000317393 contributor: fullname: Musabak – volume: 149 start-page: 192 year: 2013 ident: 10.1016/j.msard.2019.101384_bib0022 article-title: Role of puberty in multiple sclerosis risk and course publication-title: Clin. Immunol. doi: 10.1016/j.clim.2013.03.014 contributor: fullname: Chitnis |
SSID | ssj0000651461 |
Score | 2.2910442 |
Snippet | •Obesity during adolescence is a risk factor for multiple sclerosis.•We explored levels of inflammatory adipokines in pediatric MS compared to... Obesity during adolescence confers an increased risk of multiple sclerosis (MS) in both adults and children. However, obesity-mediated inflammatory mechanisms... BACKGROUNDObesity during adolescence confers an increased risk of multiple sclerosis (MS) in both adults and children. However, obesity-mediated inflammatory... |
SourceID | proquest crossref pubmed elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 101384 |
SubjectTerms | Adipokines Adiponectin - blood Adolescent Adult Biomarkers - blood Child FABP4 Fatty Acid-Binding Proteins - blood Female Humans Leptin - blood Male Multiple sclerosis Multiple Sclerosis - blood Multiple Sclerosis - diagnosis Multiple Sclerosis - physiopathology Obesity Pediatric Risk Severity of Illness Index Sex Factors Young Adult |
Title | Adipokines are associated with pediatric multiple sclerosis risk and course |
URI | https://dx.doi.org/10.1016/j.msard.2019.101384 https://www.ncbi.nlm.nih.gov/pubmed/31550559 https://search.proquest.com/docview/2297127003 |
Volume | 36 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La8MwDDZlg7HL2Hvdo3iw47ImduI4x1JWupX2shV6M07sQDeWhKa97rdPyqOwQ3fYMQY75pOQZPmTRciDLz3XSM4dT8fc8YOUO7EGgWgBMg4jiGAN1g5PZ2I8918XwaJDhm0tDNIqG9tf2_TKWjcj_QbNfrFc9t8Ynl2wjjRCM-wtsIIdnBHo9NO3t82zgIvF1tXYY45hNhAmtI8PVTSvrxIkgRSvCEe49Hc5qF0BaOWIRsfkqIkg6aDe5Anp2OyUHEybO_IzMhmYZZF_Ip2d6pWluhGANRSTrrRom3PQlkxIS1gINrMsKTLNqc4MTXJkd5yT-ej5fTh2mpYJTsKDaO0ww6WQLks8nUjXCBOmgukIgJeBsW6S2DAwJhU2DWPjJ2HkWg0RkS-thWl-wi_IXpZn9orQGFNUhguDTXIDWCRkMbOulb5MLZw6u-SxxUkV9csYqqWMfagKVoWwqhrWLhEtluqXgBXY7r8n3rfIK1B9vM_Qmc03pWIsCquLc94ll7VItjvh1dEriK7_-9sbcohfddnhLdlbrzb2DuKPddyrFKxH9gcvk_HsBz2A2EY |
link.rule.ids | 315,786,790,4521,24144,27957,27958,45620,45714 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JTsMwEB2VIgEXxE5ZjcSR0MTO4hyriqrQ5UIr9WY5sSMFRBp1ufLteLJU4lAOXB3Zsd5Ys_mNB-DR5Y6tOGOWIyNmuV7CrEgagUjfyDgIjQersHZ4NPb7U_dt5s0a0K1rYZBWWen-UqcX2roaaVdotvM0bb9TjF2wjjRENezMdmAX3Xns3_D87WwSLcbGYu9qbDJHMR1oZtSvDxU8r6-lEQVyvEIcYdzdZqG2eaCFJeodwWHlQpJOuctjaOjsBPZG1SX5KQw6Ks3nn8hnJ3KhiawkoBXBrCvJ6-4cpGYTkqVZyGwmXRKkmhOZKRLPkd5xBtPey6Tbt6qeCVbMvHBlUcW4z20aOzLmtvJVkPhUhgZ57iltx7EOPKUSXydBpNw4CG0tjUvkcq3NNDdm59DM5pm-BBJhjkoxX2GXXM8sEtCIaltzlyfahJ0teKpxEnn5NIaoOWMfooBVIKyihLUFfo2l-CVhYZT33xMfauSFOft4oSEzPV8vBaVhUNycsxZclCLZ7IQVsZcXXv33t_ew35-MhmL4Oh5cwwF-KWsQb6C5Wqz1rXFGVtFdcdh-AFxr2dg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Adipokines+are+associated+with+pediatric+multiple+sclerosis+risk+and+course&rft.jtitle=Multiple+sclerosis+and+related+disorders&rft.au=Keyhanian%2C+Kiandokht&rft.au=Saxena%2C+Shrishti&rft.au=Gombolay%2C+Grace&rft.au=Healy%2C+Brian+C&rft.date=2019-11-01&rft.pub=Elsevier+B.V&rft.issn=2211-0348&rft.eissn=2211-0356&rft.volume=36&rft_id=info:doi/10.1016%2Fj.msard.2019.101384&rft.externalDocID=S221103481930361X |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2211-0348&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2211-0348&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2211-0348&client=summon |